Tickers

1. Composite Trajectory Verdict

For a bank, the income statement and balance sheet carry the most weight because they directly reflect net interest margin dynamics, credit quality, and capital adequacy, while cash flow statements are less central to banking analysis.

Composite Trajectory: Mixed

The earnings trajectory is improving year-over-year, with net income rising 18.8% to $54.6 million (10-K 2025-12-31, Consolidated Statements of Operations) driven by higher net interest income ($142.4 million vs. $128.4 million) and noninterest income ($46.1 million vs. $41.7 million) (10-K 2025-12-31, Consolidated Statements of Operations). The balance sheet shows mixed signals: assets and deposits grew modestly (total assets +2.5% to $5.25 billion, deposits +1.8% to $4.34 billion) and equity strengthened (+19.6% to $485.7 million) (10-K 2025-12-31, Consolidated Balance Sheets), but asset quality deteriorated with nonperforming loans rising to 0.79% of total loans from 0.70% and allowance coverage falling to 142% from 162% (10-K 2025-12-31, MD&A). Operating cash flow declined 9.9% to $60.0 million despite higher net income (10-K 2025-12-31, Consolidated Statements of Cash Flows), and full investing/financing cash flow details are unavailable.

2. Red Flags

• Asset quality deterioration: Nonperforming loans to total loans increased to 0.79% at December 31, 2025 from 0.70% at December 31, 2024, driven by a single $4.4 million commercial real estate relationship moving to nonaccrual (10-K 2025-12-31, MD&A). Allowance for credit losses to nonaccrual loans coverage declined to 142.3% from 161.5% (10-K 2025-12-31, MD&A).
• Earnings-cash flow divergence: Net income rose 18.8% year-over-year to $54.6 million while net cash from operating activities fell 9.9% to $60.0 million (10-K 2025-12-31, Consolidated Statements of Operations and Consolidated Statements of Cash Flows).
• Spike in acquisition/system costs: System conversion and acquisition related costs surged to $4.0 million in 2025 from $92,000 in 2024, related to the announced Middlefield acquisition and core system conversion (10-K 2025-12-31, MD&A). Such costs may recur.
• Concentration in uninsured deposits: Uninsured deposits totaled $1.49 billion, representing 33.8% of total deposits at December 31, 2025 (10-K 2025-12-31, MD&A).
• Specific reserve build for CRE exposures: The provision included a $2.4 million increase in specific reserves for individually evaluated credits, driven by two commercial real estate non-owner occupied relationships totaling $2.1 million (10-K 2025-12-31, MD&A).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Improving

Overall Assessment: Net income increased to $54.6 million in 2025 from $45.9 million in 2024 (10-K 2025-12-31, Consolidated Statements of Operations), with diluted EPS rising to $1.45 from $1.22 (10-K 2025-12-31, Consolidated Statements of Operations). Net interest income grew 11.0% to $142.4 million, and the tax-equivalent net interest margin expanded to 2.95% from 2.69% (10-K 2025-12-31, MD&A). Noninterest income rose 10.6% to $46.1 million, led by trust fees ($11.1 million vs. $10.1 million), insurance commissions ($6.5 million vs. $5.5 million), and retirement plan consulting ($3.7 million vs. $2.6 million) (10-K 2025-12-31, MD&A). Noninterest expense increased 9.2% to $116.5 million, but $4.0 million of that was attributable to system conversion and acquisition costs (vs. $92,000 in 2024) (10-K 2025-12-31, MD&A). The provision for credit losses declined to $7.3 million from $8.2 million (10-K 2025-12-31, Consolidated Statements of Operations). The effective tax rate fell to 16.1% from 17.1% (10-K 2025-12-31, MD&A).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Insufficient Data

Overall Assessment: Only the operating cash flow section is fully available for three annual periods. Net cash from operating activities decreased to $60.0 million in 2025 from $66.6 million in 2024, after increasing from $62.9 million in 2023 (10-K 2025-12-31, Consolidated Statements of Cash Flows). The investing and financing sections of the cash flow statement are truncated in the provided XBRL data, preventing a complete assessment of cash flow trends across all activities. Quarterly cash flow statements from the 10-Q filings are not included in the provided documents.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Overall Assessment: Total assets grew 2.5% to $5.25 billion at December 31, 2025 from $5.12 billion a year earlier (10-K 2025-12-31, Consolidated Balance Sheets). Net loans increased 1.1% to $3.27 billion (10-K 2025-12-31, Consolidated Balance Sheets), while total deposits rose 1.8% to $4.34 billion (10-K 2025-12-31, Consolidated Balance Sheets). Noninterest-bearing deposits grew to $994.1 million from $965.5 million (10-K 2025-12-31, MD&A). Short-term borrowings declined to $281 million from $305 million (10-K 2025-12-31, Consolidated Balance Sheets). Stockholders' equity increased 19.6% to $485.7 million, driven by net income and a $49.2 million reduction in accumulated other comprehensive loss (10-K 2025-12-31, MD&A). However, credit quality metrics weakened: nonperforming loans to total loans rose to 0.79% from 0.70%, loans 30-89 days past due increased to 0.51% from 0.40%, and the allowance for credit losses to nonaccrual loans coverage fell to 142% from 162% (10-K 2025-12-31, MD&A). The bank remained "well capitalized" per regulatory standards (10-K 2025-12-31, MD&A).

6. Data Gaps

• Quarterly income statements, balance sheets, and cash flow statements from the 10-Q filings (2025 Q2, Q3; 2026 Q1, Q2) are not provided in the document text, preventing quarterly trend analysis.
• Full investing and financing cash flow details for 2023, 2024, and 2025 are truncated in the XBRL data.
• Risk-based capital ratios (CET1, Tier 1, Total Capital) are not explicitly disclosed in the provided excerpts; only a qualitative "well capitalized" statement is given.
• Detailed breakdown of noninterest expense components for 2023 (only 2024 and 2025 are discussed in MD&A).
• Loan yield and funding cost details for 2023 from the average balance sheet table (only 2025 and 2024 are shown).